Allogene Therapeutics, Inc. (ALLO) Tops Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts ALLO Hot Sheet
Join SI Premium – FREE
Allogene Therapeutics, Inc. (NASDAQ: ALLO) reported Q3 EPS of ($0.32), $0.01 better than the analyst estimate of ($0.33). For earnings history and earnings-related data on Allogene Therapeutics, Inc. (ALLO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- OLB Group narrows net loss 50% as revenue falls in Q2 2026
- DA Davidson Reiterates Neutral Rating on Brunswick Corp (BC)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
